Top Markets
#1 Black Phoenix Black Phoenix +21,691.70%
#2 Nesa Nesa +775.38%
#3 Cortex Cortex +69.18%
#4 Kinesis Silver Kinesis Silver +55.36%
#5 Pons Pons +25.57%
#6 QuantixAI QuantixAI +23.76%
#7 EXOD EXOD +22.78%
#8 Cash Cat Cash Cat +18.77%
#9 Derive Derive +16.76%
#10 BNB Attestation Service BNB Attestation Service +16.38%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Orphazyme A/S Orphazyme A/S

Orphazyme A/S

ORPHA
Rank in Stocks #3792
Orphazyme A/S currently conducts no significant business operations.... Orphazyme A/S currently conducts no significant business operations. Previously, the firm specialized in developing therapeutic solutions for rare neurodegenerative conditions. Established in 2009, its corporate headquarters are situated in Copenhagen, Denmark.
Share Price
$133.39
Last synced: 2024-11-19
Market Cap
$4.66B
Change (1 day)
-0.13%
Change (1 year)
0.00%
Country
DK
Trade Orphazyme A/S (ORPHA)

Category

Healthcare
P/S ratio for Orphazyme A/S (ORPHA)
P/S ratio as of 2026 TTM: 0
According to Orphazyme A/S latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Orphazyme A/S from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH